Literature DB >> 21465537

Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins.

Maoyin Pang1, Li Ma, Na Liu, Murugavel Ponnusamy, Ting C Zhao, Haidong Yan, Shougang Zhuang.   

Abstract

We recently reported that the histone deacetylase (HDAC) activity is required for activation of renal interstitial fibroblasts. In this study, we further examined the role of HDACs, in particular, HDAC1 and HDAC2, in proliferation of cultured rat renal interstitial fibroblasts (NRK-49F) and expression of cell cycle proteins. Inhibition of HDAC activity with trichostatin A (TSA), blocked cell proliferation, decreased expression of Cyclin D1, a positive cell cycle regulator, and increased expression of p27 and p57, two negative cell cycle regulators. Silencing either HDAC1 or HDAC2 with siRNA also significantly inhibited cell proliferation, decreased expression of Cyclin D1, and increased expression of p57. However, down-regulation of HDAC2, but not HDAC1 resulted in increased expression of p27. Furthermore, HDAC1 and HDAC2 down-regulation was associated with dephosphorylation and hyperacetylation of STAT3 (Signal transducer and activator of transcription 3). Blockade of STAT3 with S3I-201 or siRNA decreased renal fibroblast proliferation. Finally, mouse embryonic fibroblasts (MEFs) lacking STAT3 reduced the inhibitory effect of TSA on cell proliferation, add-back of wild type STAT3 to STAT3(-/-) MEFs restored the effect of TSA. Collectively, our results reveal an important role of HDAC1 and HDAC2 in regulating proliferation of renal interstitial fibroblasts, expression of cell cycle proteins and activation of STAT3. Further, STAT3 mediates the proliferative action of HDACs.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21465537      PMCID: PMC4626014          DOI: 10.1002/jcb.23135

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  31 in total

1.  Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Authors:  J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 2.  Histone deacetylation in epigenetics: an attractive target for anticancer therapy.

Authors:  Antonello Mai; Silvio Massa; Dante Rotili; Ilaria Cerbara; Sergio Valente; Riccardo Pezzi; Silvia Simeoni; Rino Ragno
Journal:  Med Res Rev       Date:  2005-05       Impact factor: 12.944

3.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

4.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

5.  A phosphorylation-acetylation switch regulates STAT1 signaling.

Authors:  Oliver H Krämer; Shirley K Knauer; Georg Greiner; Enrico Jandt; Sigrid Reichardt; Karl-Heinz Gührs; Roland H Stauber; Frank D Böhmer; Thorsten Heinzel
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

Review 6.  Mechanisms of kidney fibrosis and the role of antifibrotic therapies.

Authors:  Leo Deelman; Kumar Sharma
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

7.  Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts.

Authors:  James S Chen; Douglas V Faller
Journal:  J Cell Physiol       Date:  2005-01       Impact factor: 6.384

8.  Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing.

Authors:  M Shirane; Y Harumiya; N Ishida; A Hirai; C Miyamoto; S Hatakeyama; K Nakayama; M Kitagawa
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

9.  Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.

Authors:  C Leann Hinkle; Susan W Sunnarborg; David Loiselle; Carol E Parker; Mary Stevenson; William E Russell; David C Lee
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

10.  Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression.

Authors:  Teppei Yamaguchi; Fabien Cubizolles; Yu Zhang; Nina Reichert; Hubertus Kohler; Christian Seiser; Patrick Matthias
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

View more
  26 in total

Review 1.  Histone deacetylases as targets for treatment of multiple diseases.

Authors:  Jinhua Tang; Haidong Yan; Shougang Zhuang
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

2.  Integrative analysis of miRNA and mRNA paired expression profiling of primary fibroblast derived from diabetic foot ulcers reveals multiple impaired cellular functions.

Authors:  Liang Liang; Rivka C Stone; Olivera Stojadinovic; Horacio Ramirez; Irena Pastar; Anna G Maione; Avi Smith; Vanessa Yanez; Aristides Veves; Robert S Kirsner; Jonathan A Garlick; Marjana Tomic-Canic
Journal:  Wound Repair Regen       Date:  2016-10-04       Impact factor: 3.617

3.  Cross talk between histone deacetylase 4 and STAT6 in the transcriptional regulation of arginase 1 during mouse dendritic cell differentiation.

Authors:  Quan Yang; Jianyang Wei; Limei Zhong; Maohua Shi; Pan Zhou; Shengkai Zuo; Kang Wu; Mingjiang Zhu; Xi Huang; Ying Yu; Hui Zhang; Huiyong Yin; Jie Zhou
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

4.  Histone deacetylase inhibitor enhances recovery after AKI.

Authors:  Chiara Cianciolo Cosentino; Nataliya I Skrypnyk; Lauren L Brilli; Takuto Chiba; Tatiana Novitskaya; Clara Woods; James West; Vasiliy N Korotchenko; Lee McDermott; Billy W Day; Alan J Davidson; Raymond C Harris; Mark P de Caestecker; Neil A Hukriede
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

5.  Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis.

Authors:  Murugavel Ponnusamy; Michelle A Zhuang; Xiaoxu Zhou; Evelyn Tolbert; George Bayliss; Ting C Zhao; Shougang Zhuang
Journal:  J Pharmacol Exp Ther       Date:  2015-05-28       Impact factor: 4.030

6.  Critical review of non-histone human substrates of metal-dependent lysine deacetylases.

Authors:  Tasha B Toro; Terry J Watt
Journal:  FASEB J       Date:  2020-08-30       Impact factor: 5.191

7.  P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells.

Authors:  Jun Ni; Yang Shen; Zhen Wang; De-cui Shao; Jia Liu; Ya-li Kong; Lan-jun Fu; Li Zhou; Hong Xue; Yu Huang; Wei Zhang; Chen Yu; Li-min Lu
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

8.  Histone deacetylase 1 reduces NO production in endothelial cells via lysine deacetylation of NO synthase 3.

Authors:  Kelly A Hyndman; Dao H Ho; Martiana F Sega; Jennifer S Pollock
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

9.  Class I histone deacetylase activity is required for proliferation of renal epithelial cells.

Authors:  Jinhua Tang; Yanli Yan; Ting C Zhao; George Bayliss; Haidong Yan; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-22

10.  Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney.

Authors:  Jun Ni; Yang Shen; Zhen Wang; De-cui Shao; Jia Liu; Lan-jun Fu; Ya-li Kong; Li Zhou; Hong Xue; Yu Huang; Wei Zhang; Chen Yu; Li-min Lu
Journal:  Acta Pharmacol Sin       Date:  2014-06-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.